All In MedTech

Company

Nevro

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Total raised (reported)

$58.6M

1 Form D offering, 2011 to 2011

Equity

$58.6M

Stock sold for cash

Debt and convertible notes

$0

Loans and notes sold to investors

Last known valuation

Unknown

Form D filings do not report valuation

Latest round: equity, $58.6M raised of $58.6M sought, first sale Jul 15, 2011, 13 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Jul 15, 2011Equity$58.6M$58.6M13Rule 506Form D ↗Jul 28, 2011

Company details

From the company's latest Form D.

Legal name
NEVRO CORP
Headquarters
Menlo Park, California
Incorporated
Delaware in 2006
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Biotechnology

Executives, directors and promoters

As listed on the latest Form D.

    10 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    No 5%+ shareholder filings or SBIR grants found under the name Nevro.

    Latest FDA decisions

    Search the Clearance Tracker

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    7 more trials with a free account

    Reports received

    680

    Received Nov 1, 2025 to Nov 20, 2026. Includes 3 of another or unstated type.

    Malfunction reports

    24

    3.5% of reports

    Injury reports

    650

    96% of reports

    Death reports

    3

    0.4% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 23546130
    Jan 24156171
    Feb 24890190
    Mar 24364280
    Apr 24469160
    May 24286200
    Jun 24390300
    Jul 24278310
    Aug 24380310
    Sep 24080130
    Oct 2429000
    Nov 2488300
    Dec 2416700
    Jan 25211900
    Feb 2507400
    Mar 2537800
    Apr 2548420
    May 2537420
    Jun 2538800
    Jul 2545500
    Aug 2506100
    Sep 2527620
    Oct 25010610
    Nov 2537100
    Dec 2506110
    Jan 2614000
    Feb 2624100
    Mar 2645710
    Apr 2627400
    May 2645501
    Jun 2664500
    Jul 2614500
    Aug 2615502
    Sep 2605600
    Oct 2605010
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    No recalls under this name in FDA's data.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.